Pfizer Headquarters Conversion Advances in Midtown East

• Construction is progressing on the conversion of the former Pfizer headquarters at 219-229 East 42nd Street into 1,600 rental apartments.
• Metro Loft Development and David Werner Real Estate Investments are redeveloping the property, with 25% of the units designated as affordable housing.
• The project will also include ground-floor retail space and approximately 100,000 square feet of resident amenities, with completion expected in 2027.

What Is Happening at 219-229 East 42nd Street

Work continues to move forward on one of New York City's largest office-to-residential conversion projects at the former Pfizer headquarters in Midtown East. Located at the northwest corner of East 42nd Street and Second Avenue, the redevelopment encompasses both 229 East 42nd Street and the adjacent property at 219 East 42nd Street. Developed by Metro Loft Development and David Werner Real Estate Investments and designed by Gensler, the project combines the conversion of an existing office tower with a substantial vertical expansion of the neighboring building.

What the Conversion Includes

The redevelopment centers on the complete transformation of the former 33-story Pfizer office tower. Construction crews have significantly advanced the recladding of the building's exterior, replacing much of the original façade with a modern system featuring ribbed white paneling and updated window installations. Once completed, the project will deliver approximately 1,600 rental apartments. Twenty-five percent of the units will be set aside as affordable housing, making the development one of the larger mixed-income residential projects currently underway in Manhattan. In addition to housing, plans call for ground-floor retail space and roughly 100,000 square feet of amenities designed for residents.

What Progress Has Been Made on the Expansion

Construction is also advancing on the neighboring building at 219 East 42nd Street. The structure's reinforced concrete superstructure has already topped out, reaching its planned 29-story height. Exterior enclosure work is nearing completion as crews continue installing the glass curtain wall system. The expansion adds significant residential capacity to the overall development while helping reshape a formerly office-focused property into a large-scale residential complex.

What Amenities Will Be Available

Residents will have access to a variety of lifestyle amenities, including a rooftop swimming pool and fitness center. Additional amenities are expected to be announced as construction progresses. The property's location near Grand Central Terminal provides direct access to the 4, 5, 6, 7, and Shuttle subway lines, Metro-North Railroad service, and the Long Island Rail Road through Grand Central Madison, making it one of the most transit-connected residential developments in Manhattan.

What This Project Means for Manhattan's Office Market

The former Pfizer headquarters redevelopment highlights the growing role of office-to-residential conversions in New York City's housing strategy. As older office buildings face shifting demand patterns, developers are increasingly repositioning well-located assets into residential properties that can help address housing shortages while revitalizing aging commercial inventory. For Metro Loft Development, led by Nathan Berman, and David Werner Real Estate Investments, the project represents another major adaptive reuse effort that could serve as a model for future office conversions across Manhattan. Construction is expected to conclude sometime in 2027.